Nat Med. 2025 Oct 6. doi: 10.1038/s41591-025-03971-6. Online ahead of print. ABSTRACT Psoriatic arthritis (PsA) is a progressive, multidomain and […]
Sci Rep. 2025 Oct 6;15(1):34747. doi: 10.1038/s41598-025-18298-y. ABSTRACT To identify clinical features that predict the risk of meeting difficult-to-treat (D2T)
Sci Rep. 2025 Oct 6;15(1):34748. doi: 10.1038/s41598-025-18370-7. ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by
Sci Rep. 2025 Oct 6;15(1):34768. doi: 10.1038/s41598-025-18594-7. ABSTRACT Diabetes mellitus (DM) management has advanced from self-monitoring blood glucose (SMBG) to
Cell Death Discov. 2025 Oct 6;11(1):428. doi: 10.1038/s41420-025-02709-0. ABSTRACT Subretinal fibrosis, a consequence of choroidal neovascularization (CNV) in age-related macular
Nat Commun. 2025 Oct 6;16(1):8855. doi: 10.1038/s41467-025-63915-z. ABSTRACT Simultaneous profiling of spatial transcriptomics (ST) and spatial metabolomics (SM) on the
BMJ Lead. 2025 Oct 6:leader-2025-001400. doi: 10.1136/leader-2025-001400. Online ahead of print. ABSTRACT BACKGROUND: Shared decision-making (SDM) is a cornerstone of
RMD Open. 2025 Oct 5;11(4):e005614. doi: 10.1136/rmdopen-2025-005614. ABSTRACT OBJECTIVE: To estimate risk and to identify risk factors for preterm birth
RMD Open. 2025 Oct 5;11(4):e005866. doi: 10.1136/rmdopen-2025-005866. ABSTRACT Early data have shown the potential of chimeric antigen receptor (CAR) T-cell
RMD Open. 2025 Oct 5;11(4):e005231. doi: 10.1136/rmdopen-2024-005231. ABSTRACT Multisystem inflammatory syndrome in children (MIS-C) is a severe SARS-CoV-2-associated condition that
RMD Open. 2025 Oct 5;11(4):e006031. doi: 10.1136/rmdopen-2025-006031. ABSTRACT OBJECTIVES: To evaluate disease evolution, diagnostic transitions, time to biologic treatment initiation
RMD Open. 2025 Oct 5;11(4):e005879. doi: 10.1136/rmdopen-2025-005879. ABSTRACT OBJECTIVES: To explore the prevalence and distribution of ultrasound-detected inflammation and structural
Stem Cell Res. 2025 Sep 22;89:103843. doi: 10.1016/j.scr.2025.103843. Online ahead of print. ABSTRACT Mutations in the MMACHC (metabolism of cobalamin
Female rheumatologists have better patient outcomes: study. Rheumatoid arthritis. By Siobhan Calafiore. 7 Oct 2025. A provocative study has found …
The group of rheumatologists, which included Professor Mandana Nikpour from University of Sydney and Royal Prince Alfred Hospital, Sydney, conducted
It provides clues for the diagnosis, prognosis and monitoring of a variety of complex diseases, including rheumatic and immune diseases.
USA: A new study published in Arthritis & Rheumatology found that patients with lupus and type 2 diabetes, including those
German survey of 124 AOSD pts – Dz duration 7 yrs (Dx delay 2 yrs), 2/3 on biologics, 84% responding,
Vasc Endovascular Surg. 2025 Oct 6:15385744251387775. doi: 10.1177/15385744251387775. Online ahead of print. ABSTRACT PurposeTo describe a case of recurrent cerebral
Am J Respir Crit Care Med. 2025 Oct 6. doi: 10.1164/rccm.202506-1373LE. Online ahead of print. NO ABSTRACT PMID:41052459 | DOI:10.1164/rccm.202506-1373LE
PLoS One. 2025 Oct 6;20(10):e0333022. doi: 10.1371/journal.pone.0333022. eCollection 2025. ABSTRACT OBJECTIVES: To evaluate if self-assessed rheumatic disease activity in patients
Kidney360. 2025 Oct 6. doi: 10.34067/KID.0000000997. Online ahead of print. ABSTRACT BACKGROUND: Reliable prognostic biomarkers of nephrotic syndrome (NS) are
Phase 3 RCT Cannabis sativa DKJ127 (VER-1) in 820 chronic low back pain (cLBP) pts. Primary endpt at wk 12
… Rheumatic Diseases vs. Primary Osteoarthritis … 1Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO Institute, Milan, Italy …
… rheumatology at the karolinska institutet announces the winners of the 2025. Marie Wahren-Herlenius, Professor of Rheumatology at the Karolinska …
Systematic review of obesity management meds – 56 RCTs (60,307 pts). All OMMs were better at total weight loss than
These were combining biologic therapies with conventional disease-modifying anti-rheumatic drugs (DMARDs) during pregnancy, halting biologic therapy …
